888 related articles for article (PubMed ID: 15563286)
1. Addressing nonlinearity in the exposure-response relationship for a genotoxic carcinogen: cancer potency estimates for ethylene oxide.
Kirman CR; Sweeney LM; Teta MJ; Sielken RL; Valdez-Flores C; Albertini RJ; Gargas ML
Risk Anal; 2004 Oct; 24(5):1165-83. PubMed ID: 15563286
[TBL] [Abstract][Full Text] [Related]
2. Cancer dose--response assessment for acrylonitrile based upon rodent brain tumor incidence: use of epidemiologic, mechanistic, and pharmacokinetic support for nonlinearity.
Kirman CR; Gargas ML; Marsh GM; Strother DE; Klaunig JE; Collins JJ; Deskin R
Regul Toxicol Pharmacol; 2005 Oct; 43(1):85-103. PubMed ID: 16099568
[TBL] [Abstract][Full Text] [Related]
3. Chloroform mode of action: implications for cancer risk assessment.
Golden RJ; Holm SE; Robinson DE; Julkunen PH; Reese EA
Regul Toxicol Pharmacol; 1997 Oct; 26(2):142-55. PubMed ID: 9356278
[TBL] [Abstract][Full Text] [Related]
4. Regulatory cancer risk assessment based on a quick estimate of a benchmark dose derived from the maximum tolerated dose.
Gaylor DW; Swirsky Gold L
Regul Toxicol Pharmacol; 1998 Dec; 28(3):222-5. PubMed ID: 10049793
[TBL] [Abstract][Full Text] [Related]
5. Cancer risk assessment for 1,3-butadiene: data integration opportunities.
Preston RJ
Chem Biol Interact; 2007 Mar; 166(1-3):150-5. PubMed ID: 16647696
[TBL] [Abstract][Full Text] [Related]
6. Update of potency factors for asbestos-related lung cancer and mesothelioma.
Berman DW; Crump KS
Crit Rev Toxicol; 2008; 38 Suppl 1():1-47. PubMed ID: 18671157
[TBL] [Abstract][Full Text] [Related]
7. Strategy for genotoxicity testing: hazard identification and risk assessment in relation to in vitro testing.
Thybaud V; Aardema M; Clements J; Dearfield K; Galloway S; Hayashi M; Jacobson-Kram D; Kirkland D; MacGregor JT; Marzin D; Ohyama W; Schuler M; Suzuki H; Zeiger E;
Mutat Res; 2007 Feb; 627(1):41-58. PubMed ID: 17126066
[TBL] [Abstract][Full Text] [Related]
8. Ethyl methanesulfonate toxicity in Viracept--a comprehensive human risk assessment based on threshold data for genotoxicity.
Müller L; Gocke E; Lavé T; Pfister T
Toxicol Lett; 2009 Nov; 190(3):317-29. PubMed ID: 19443141
[TBL] [Abstract][Full Text] [Related]
9. Acrylamide: review of toxicity data and dose-response analyses for cancer and noncancer effects.
Shipp A; Lawrence G; Gentry R; McDonald T; Bartow H; Bounds J; Macdonald N; Clewell H; Allen B; Van Landingham C
Crit Rev Toxicol; 2006; 36(6-7):481-608. PubMed ID: 16973444
[TBL] [Abstract][Full Text] [Related]
10. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
Gaylor DW
Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
[TBL] [Abstract][Full Text] [Related]
11. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
[TBL] [Abstract][Full Text] [Related]
12. Human respiratory tract cancer risks of inhaled formaldehyde: dose-response predictions derived from biologically-motivated computational modeling of a combined rodent and human dataset.
Conolly RB; Kimbell JS; Janszen D; Schlosser PM; Kalisak D; Preston J; Miller FJ
Toxicol Sci; 2004 Nov; 82(1):279-96. PubMed ID: 15254341
[TBL] [Abstract][Full Text] [Related]
13. Quantitative cancer risk assessment based on NIOSH and UCC epidemiological data for workers exposed to ethylene oxide.
Valdez-Flores C; Sielken RL; Teta MJ
Regul Toxicol Pharmacol; 2010 Apr; 56(3):312-20. PubMed ID: 19840826
[TBL] [Abstract][Full Text] [Related]
14. Reducing uncertainty in risk assessment by using specific knowledge to replace default options.
McClellan RO
Drug Metab Rev; 1996; 28(1-2):149-79. PubMed ID: 8744594
[TBL] [Abstract][Full Text] [Related]
15. Quantitative cancer risk assessment for ethylene oxide inhalation in occupational settings.
Valdez-Flores C; Sielken RL; Teta MJ
Arch Toxicol; 2011 Oct; 85(10):1189-93. PubMed ID: 21347664
[TBL] [Abstract][Full Text] [Related]
16. Revised assessment of cancer risk to dichloromethane II. Application of probabilistic methods to cancer risk determinations.
David RM; Clewell HJ; Gentry PR; Covington TR; Morgott DA; Marino DJ
Regul Toxicol Pharmacol; 2006 Jun; 45(1):55-65. PubMed ID: 16439044
[TBL] [Abstract][Full Text] [Related]
17. A strategy for establishing mode of action of chemical carcinogens as a guide for approaches to risk assessments.
Butterworth BE; Conolly RB; Morgan KT
Cancer Lett; 1995 Jun; 93(1):129-46. PubMed ID: 7600540
[TBL] [Abstract][Full Text] [Related]
18. Life-table calculations of excess risk for incidence versus mortality: ethylene oxide case study.
Sielken RL; Valdez-Flores C
Regul Toxicol Pharmacol; 2009 Oct; 55(1):82-9. PubMed ID: 19508882
[TBL] [Abstract][Full Text] [Related]
19. Effects of ethylene oxide and ethylene inhalation on DNA adducts, apurinic/apyrimidinic sites and expression of base excision DNA repair genes in rat brain, spleen, and liver.
Rusyn I; Asakura S; Li Y; Kosyk O; Koc H; Nakamura J; Upton PB; Swenberg JA
DNA Repair (Amst); 2005 Sep; 4(10):1099-110. PubMed ID: 16051529
[TBL] [Abstract][Full Text] [Related]
20. Application of the Margin of Exposure (MOE) approach to substances in food that are genotoxic and carcinogenic.
Benford D; Bolger PM; Carthew P; Coulet M; DiNovi M; Leblanc JC; Renwick AG; Setzer W; Schlatter J; Smith B; Slob W; Williams G; Wildemann T
Food Chem Toxicol; 2010 Jan; 48 Suppl 1():S2-24. PubMed ID: 20113851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
